Professor Johann de Bono, the Head of the Oak Drug Development Unit at The Royal Marsden and The Institute of Cancer Research (ICR), has been

A new streamlined approach to genetic testing for women with ovarian cancer provides testing rapidly and affordably, allowing many more patien

Genetic testing in men with advanced prostate cancer could pick up a significant proportion whose disease may be caused by inherited mutations

The installation of the UK's first MR Linac made significant progress at The Royal Marsden and Institute of Cancer Research (ICR) this summer.

Changing the intensity of radiotherapy to protect the salivary glands could help treat a rare type of head and neck cancer and improve patient

The research, published in Clinical Cancer Research journal, could form the basis of future tests to direct treatment to cancers that have res

Researchers have uncovered a key part of a chain reaction of signals that tell some lung cancers to grow. This new insight into a major cancer

Breast cancer cells can become resistant to a common anticancer drug in a variety of different ways, suggesting that tailored treatment combin

The National Institute for Health Research (NIHR) is committed to encouraging non-medical healthcare clinicians to undertake research training

Pilot study will sequence 81 cancer genes in children’s tumours to help personalise cancer treatment.